Ignite Creation Date:
2024-05-06 @ 5:51 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05457374
Status:
RECRUITING
Last Update Posted:
2022-07-14
First Post:
2022-07-10
Brief Title:
A Clinical Study of Portal Vein Embolization and Liver Venous Deprivation
Sponsor:
Anhui Provincial Hospital
Organization:
Anhui Provincial Hospital
Study Overview
Official Title:
A Clinical Study of Portal Vein Embolization and Liver Venous Deprivation
Status:
RECRUITING
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main obstacle to achieving R0 resection in future liver remnantFLR deficient liver cancer is the inability to retain sufficient FLR to avoid postoperative liver failure From the initial portal vein embolizationPVE to the later ALPPS this problem has been solved to some extent However both have their own shortcomings The effect of liver hyperplasia after PVE is poor and the waiting time is long The incidence of complication and mortality after ALPPS is always the focus of controversy In recent years LVD has emerged combining PVE and HVE in the one operation This topic will conduct a clinical controlled study of PVE and LVD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None